Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220017279 220019750 1.56 null null null 2015-01-08 Dasatinib N N 220029738 DASATINIB
220017280 220007713 1.56 null Disease modification (D) 2016-08-13 2016-10-24 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N null 220029739 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017281 220007714 1.64 null Palliative (P) 2017-11-26 2017-12-03 Dasatinib N N 220029746 DASATINIB
220017282 220014245 1.74 0 Curative (C) 2015-01-08 2015-01-08 Dasatinib N N 220029749 DASATINIB
220017283 220014246 1.63 57.8 Curative (C) 2013-06-06 2013-08-20 Alemtuz+Fludara+Melphalan RIC MUD N N 220029751 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017284 220007721 1.66 79.2 Curative (C) 2018-08-20 2018-08-31 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 01 null 220029754 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017285 220007721 1.52 null Curative (C) 2017-08-06 2017-08-07 Rituximab (Maintenance) N N 220029754 RITUXIMAB
220017286 220007722 1.71 100 Curative (C) 2016-05-11 2016-08-16 AML 18 TRIAL N N 220029756 AML18 TRIAL
220017287 220007724 1.68 null Curative (C) null 2016-01-11 Rituximab N N 220029760 RITUXIMAB
220017288 220007725 1.7 85.9 Curative (C) 2016-04-27 2016-06-05 AML18 PILOT TRIAL Y N 220029762 PILOT TRIAL
220017289 220007729 1.7 69.4 Curative (C) null 2015-03-24 AML18 PILOT TRIAL null N 220029771 PILOT TRIAL
220017290 220007732 1.59 78 Curative (C) 2017-08-22 2017-11-26 AML18 PILOT TRIAL 01 N 220029775 PILOT TRIAL
220017291 220007733 1.61 null Curative (C) 2018-12-28 2019-01-04 Dasatinib 99 N 220029778 DASATINIB
220017292 220014256 0 0 Curative (C) 2016-09-08 2016-11-05 Dasatinib N N 220029779 DASATINIB
220017293 220007735 1.75 84.9 Disease modification (D) 2015-01-15 2015-01-15 Rituximab N N 220029786 RITUXIMAB
220017294 220017781 null null Curative (C) 2013-12-08 2013-12-10 Rituximab 02 N 220029798 RITUXIMAB
220017295 220007739 null 81.9 Disease modification (D) 2014-01-15 2014-01-15 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220029804 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017296 220014261 1.55 104.8 Curative (C) 2015-12-22 2016-02-13 AML 18 TRIAL null N 220029808 AML18 TRIAL
220017297 220007742 1.77 68.1 Curative (C) 2017-11-09 2017-11-09 Dasatinib N N 220029810 DASATINIB
220017298 220007744 1.75 53.5 Curative (C) null 2016-04-19 AML18 PILOT TRIAL N N 220029817 PILOT TRIAL
220017302 220007761 1.71 82.8 Curative (C) 2013-06-20 2013-08-05 AML18 PILOT TRIAL null null 220029867 PILOT TRIAL
220017303 220007764 1.76 0 Adjuvant (A) null 2017-06-13 Rituximab 2 null 220029884 RITUXIMAB
220017304 220007765 1.62 76.9 Disease modification (D) 2017-05-25 2017-09-04 Dasatinib N N 220029889 DASATINIB
220017305 220007768 null null Disease modification (D) 2016-02-16 2016-02-16 Dasatinib 02 N 220029890 DASATINIB
220017306 220020894 null 70 Curative (C) 2018-05-27 2018-07-08 AML18 PILOT TRIAL 1 N 220029900 PILOT TRIAL
220017307 220007769 0 95.8 Disease modification (D) 2017-10-05 2018-07-13 Dasatinib 99 N 220029903 DASATINIB
220017308 220017789 1.62 80.75 Disease modification (D) 2013-11-17 2013-11-20 AML 18 TRIAL 01 N 220029906 AML18 TRIAL
220017309 220007774 0 49.9 Disease modification (D) 2013-10-11 2013-12-12 AML 18 TRIAL 01 N 220029925 AML18 TRIAL
220017310 220007775 1.71 64.2 Disease modification (D) 2017-01-31 2017-02-01 Dasatinib N N 220029931 DASATINIB
220017311 220007775 1.63 71.4 Curative (C) 2018-01-23 2018-01-25 Alemtuz+Fludara+Melphalan RIC MUD N N 220029931 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017312 220007777 1.62 63.1 Curative (C) 2014-11-04 2014-11-07 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N null 220029945 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017313 220007777 1.75 71.8 Curative (C) 2015-10-29 2015-10-29 AML 18 TRIAL null null 220029945 AML18 TRIAL
220017314 220007778 null 102.2 Curative (C) null 2013-10-10 Dasatinib N N 220029951 DASATINIB
220017315 220007779 1.75 75 Curative (C) 2015-09-06 2016-05-09 Dasatinib 99 null 220029952 DASATINIB
220017316 220007783 1.62 66 Curative (C) null 2014-08-16 AML 18 TRIAL N N 220029966 AML18 TRIAL
220017317 220019761 null 88.7 null null 2014-05-21 AML 18 TRIAL 1 N 220029980 AML18 TRIAL
220017318 220007788 1.76 86 Curative (C) 2014-10-15 2014-10-16 AML 18 TRIAL 01 null 220029989 AML18 TRIAL
220017319 220007791 1.59 56.7 Disease modification (D) null 2018-11-07 AML 18 TRIAL 01 N 220029990 AML18 TRIAL
220017320 220017797 null null Disease modification (D) 2015-08-19 2015-08-19 Dasatinib null null 220029995 DASATINIB
220017321 220007794 null 80.75 Palliative (P) 2017-08-20 2017-10-17 AML 18 TRIAL N N 220030009 AML18 TRIAL
220017322 220007795 null 80 Disease modification (D) 2017-03-18 2017-03-21 Dasatinib N N 220030022 DASATINIB
220017324 220007798 1.7 78 null 2016-03-25 2016-08-17 Rituximab N N 220030037 RITUXIMAB
220017325 220007801 1.9 null Curative (C) 2018-10-21 2018-10-21 Rituximab N N 220030042 RITUXIMAB
220017326 220007803 1.59 61.6 Curative (C) 2017-05-22 2017-05-22 Rituximab N N 220030047 RITUXIMAB
220017327 220007808 1.86 null Neo-adjuvant (N) 2016-08-03 2016-10-29 Rituximab N N 220030054 RITUXIMAB
220017328 220007812 null 81 Curative (C) 2013-09-29 2013-11-08 AML 18 Pilot Trial N null 220030060 PILOT TRIAL
220017329 220007813 1.84 64.75 Disease modification (D) 2014-10-31 2014-10-31 Rituximab null N 220030065 RITUXIMAB
220017330 220014300 1.85 80.75 Curative (C) 2017-12-08 2018-01-01 AML 18 TRIAL Y N 220030066 AML18 TRIAL
220017331 220007817 1.56 63 Curative (C) 2016-01-15 2016-01-15 Alemtuz+Fludara+Melphalan RIC MUD N Y 220030069 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017332 220007818 null 138.8 Curative (C) null 2016-10-28 AML 18 TRIAL Y null 220030073 AML18 TRIAL